association of serum bilirubin levels with admission severity and short term clinical outcomes among acute ischemic stroke patients.
METHODS

Study participants
This cross-sectional and follow-up study was conducted between 1 January 2006 and 31 December 2008 in four hospitals of Shandong Province, China. Two thousand, six hundred and seventy five acute ischemic patients, confirmed by a computed tomography (CT) scan or magnetic resonance imaging (MRI), were investigated. Three hundred and fourteen patients were excluded for missing data of bilirubin or other covariates. Stroke patients who were not admitted into the four hospitals including those who died outside of hospitals were not included in this analysis. This study was approved by Soochow University School of Public Health Ethics Committee.
Data collection
baseline data were collected within the first 24 hours of hospital admission by in-person interview with patients or their family members (if patients were not able to communicate). Data on demographic characteristics, life-style risk factors, medical history, clinical laboratory tests, and imaging data (CT and MRI) were obtained using a standard questionnaire administered by trained staff. Cigarette smokers were defined as having smoked at least one cigarette per day for one year or more. Data on the amount and type of alcohol consumed during the past year were collected. Alcohol consumption was defined as consuming one or more alcoholic drinks per day during the last year. blood pressure measurements were taken within 30 minutes of admission and in the first 72 hours (one measurement every eight hours) after admission while the study participants were in the supine position using a standard mercury sphygmomanometer according to a standard protocol 11 .
blood specimens were collected from all subjects within 24 hours of hospital admissionafter fasting (at least eight hours). Total bilirubin (Tbil) was measured by the 2,5-dichlorophenyldiazonium (DPD) method 12 and direct bilirubin (Dbil) was measured by the method of Jendrassik et al 13 . Modified hexokinase enzymatic method was applied to test plasma glucose levels 14 . Total cholesterol, high-density lipoprotein (HDL)-cholesterol, and triglycerides were analyzed enzymatically on a beckman Synchron CX5 Delta Clinical System (beckman Coulter, Inc., Fullerton, California, USA) using commercial reagents 15 . Low-density lipoprotein (LDL)-cholesterol levels were calculated using Friedewald equation 16 . A comprehensive clinical evaluation with National Institutes of Health stroke scale (NIHSS) was conducted at admission and discharge. If a patient died in the hospital, a study staff member recorded the death on the event form and obtained the death certificate. In admission, NIHSS≥10 was considered as higher severity (primary outcome) in the cross-sectional analysis. NIHSS≥10 at discharge or in-hospital death was defined as short term clinical outcomes (secondary outcome) in the follow-up analysis 17 .
Statistical analysis
The unadjusted means and standard deviations (SD) of normally-distributed continuous variables, mean ranks of ordinal variables and prevalence of categorical variables were calculated for baseline characteristics according to different admission severity and discharge status. Analysis of variance was used to calculate P values for difference in the means of continuous variables. Rank sum test was used to calculate P values for difference in mean ranks of ordinal variables. χ 2 test or Fisher exact test was used to calculate P values for difference in the prevalence of categorical variables. We used dichotomous variable as an outcome based on NIHSS≥10/death or NIHSS<10 and used Tbil and Dbil as exposures, which were quartile in the logistic regression model adjusted for age, sex, and other confounders and potential confounders in order to get unbiased parameter estimates. We also carefully examined collinearity between exposure and other confounders in the model and found there is no severe collinearity since all variance inflation factors (vIFs) between bilirubin and confounders were under 2.5. We did linear trend tests using Tbil and Dbil as continuous variables in the logistic regression. All P values were two-tailed and a significance level of 0.05 was used. Statistical analysis was conducted using SAS statistical software (version 9.13; SAS Institute Inc, Cary, North Carolina, USA).
RESULTS
A total of 2361 acute ischemic stroke patients were included in our analysis. Table 1 presents the demographic and clinical characteristics by admission NIHSS. Those with higher admission NIHSS were more likely to be male and older, have higher alcohol consumption, systolic blood pressure (bP) levels, plasma glucose, serum Tbil, serum Dbil and lower triglycerides, have higher rates of histories of stroke, atrial fibrillation and rheumatic heart disease. Statistically significant differences were found in the mean of age, alcohol consumption, blood pressure, plasma glucose, serum Tbil, serum Dbil, triglycerides and the proportion of men, in-hospital complications, histories of diabetes and atrial fibrillation among three groups divided by discharge status (Table 2) .
Age and sex-adjusted and multivariable-adjusted odds ratios of admission severity by the quartiles of Tbil and Dbil are presented in Table 3 . The age and sex-adjusted odds ratios of severity were significantly higher in the third and top quartiles of Tbil and Dbil. The multivariable-adjusted odds ratios of severity were significantly higher in the top quartile of Tbil and the third and top quartiles of Dbil. There was a dose-response relationship between Tbil/Dbil levels and admission severity (all P values for linear trend were less than 0.05). However, serum Tbil/Dbil levels were not significantly associated with short clinical outcomes including discharge NIHSS≥10 or death inhospital after confounding factors adjusted.
DISCUSSION
The primary findings of this study are that elevated levels of serum Tbil and Dbil are associated with increased odds of admission severity in acute ischemic stroke patients. In contrast, both serum levels of Tbil and Dbil are poor prognostic factors for acute ischemic stroke in a short term. our findings are consistent with other studies that have reported a significant association between elevated bilirubin levels and greater stroke severity instead of patients' outcome 18, 19 . However, in these studies, only Dbil levels showed a significant association with stroke severity on admission whereas Tbil did not. A possible reason for this discrepancy is that several studies have suggested Dbil level is more sensitive among individuals with general medical conditions [20] [21] [22] . However, the sample size of our study is more than three fold the previous study, so that a relationship between serum Tbil levels and stroke severity is more likely to be discovered.
The generation of free radicals leading to oxidative stress is one of the mechanisms involved in brain damage induced by ischemia 23, 24 . bilirubin, which, for many years, was thought to have no physiological function other than that of a waste product of heme catabolism, has been proved a potent antioxidant 5, 6 . Dohi et al suggested that serum bilirubin might serve as a useful marker of oxidative stress in hemorrhagic stroke patients and high levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging 25 . our results also indicated that the production of bilirubin in serum could be attributable to systemic oxidative stresses caused by vascular and brain damage, which could occur after stroke via heme oxygenases pathway activation 26 . Therefore, further study is warranted to investigate the relationship between serum bilirubin and oxidative stress and to confirm that the concentration of serum bilirubin may reflect intensity of oxidative stress, which may be closely associated with degree of stroke severity in our population.
A study including 453 stroke patients indicated that increment in bilirubin level was associated with reduced odds of an adverse stroke outcome. A possible explanation for this inconsistency is that admission severity was not chosen as an adjusted variable in multivariable model in this study 27 . As a matter of fact, admission severity was considered as a strong confounding factor influencing prognosis among stroke patients 28 , especially in our study which focused on short-term clinical outcomes. This is the largest study in a Chinese population to examine the association of serum bilirubin levels with stroke admission severity and short-term clinical outcomes. The study data were collected with rigid quality control and important covariate variables were measured and controlled in the analysis. However, two limitations of this study should be mentioned. Firstly, association between serum bilirubin levels and admission severity was analyzed in a cross-sectional study. Therefore, a causal relationship between them could not be established. Secondly, the follow-up period of our study is relatively short, which prevented an evaluation of the long-term effects of serum bilirubin levels on acute ischemic stroke outcomes. Although serum bilirubin level may be used as a biomarker in predicting severity of stroke in our study, future research comparing bilirubin levels among stroke patients, healthy people, and other neurological disorders are warranted in Chinese population.
CONCLUSION
In summary, our study found that serum levels of bilirubin were significantly and positively associated with admission NIHSS≥10. A significant association was not observed between serum bilirubin levels and death or NIHSS≥10 at discharge.
Primary outcome: In admission, NIHSS≥10 was considered higher severity. Multivariable adjustment included age, sex, alcohol consumption, cigarette smoking, blood levels of glucose and lipids, admission SbP and DbP, blood urea nitrogen, serum creatinine, sodium, hematocrit, history of stroke, hypertension, diabetes, coronary heart disease, rheumatic heart disease, and atrial fibrillation, family history of stroke, hypertension and diabetes. SbP=systolic blood pressure, DbP=diastolic blood pressure. * p values for linear trends were estimated by using bilirubin as continuous variables in multiple logistic models. 
